The role of pseudotype neutralization assays in understanding SARS CoV-2. (2021)
Attributed to:
nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/oxfimm/iqab005
PubMed Identifier: 33738456
Publication URI: http://europepmc.org/abstract/MED/33738456
Type: Journal Article/Review
Volume: 2
Parent Publication: Oxford open immunology
Issue: 1
ISSN: 2633-6960